Reliability of Portable Spirometry Performed in the Korea National Health and Nutrition Examination Survey Compared to Conventional Spirometry by 박혜정
274
Reliability of Portable Spirometry Performed 
in the Korea National Health and Nutrition 
Examination Survey Compared to 
Conventional Spirometry
Hye Jung Park, M.D., Ph.D.1 , Chin Kook Rhee, M.D., Ph.D.2, Kwang Ha Yoo, M.D., Ph.D.3 and 
Yong Bum Park, M.D.4  
1Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, 2Division 
of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, 
The Catholic University of Korea, Seoul, 3Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal 
Medicine, Konkuk University School of Medicine, Seoul, 4Division of Pulmonary, Allergy, and Critical Care Medicine, 
Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital, Seoul, Republic of Korea
Background: The Korea National Health and Nutrition Examination Survey (KNHANES) is a well-designed survey to 
collect national data, which many researchers have used for their studies. In KNHANES, although portable spirometry 
was used, its reliability has not been verified.
Methods: We prospectively enrolled 58 participants from four Korean institutions. The participants were classified into 
normal pattern, obstructive pattern, and restrictive pattern groups according to their previous spirometry results. Lung 
function was estimated by conventional spirometry and portable spirometry, and the results were compared.
Results: The intraclass correlation coefficients of forced vital capacity (FVC) (coefficient, 9.993; 95% confidence interval 
[CI], 0.988–0.996), forced expiratory volume in 1 second (FEV1) (coefficient, 0.997; 95% CI, 0.995–0.998), FEV1/FVC 
ratio (coefficient, 0.995; 95% CI, 0.992–0.997), and forced expiratory flow at 25–75% (FEF25–75%; coefficient, 0.991; 95% 
CI, 0.984–0.994) were excellent (all p<0.001). In the subgroup analysis, the results of the three parameters were similar 
in all groups. In the overall and subgroup analyses, Pearson’s correlation of all the parameters was also excellent in the 
total (coefficient, 0.986–0.994; p<0.001) and subgroup analyses (coefficient, 0.915–0.995; p<0.001). In the paired t-test, 
FVC, FEV1/FVC, and FEF25–75% estimated by the two instruments were statistically different. However, FEV1 was not 
significantly different. 
Conclusion: Lung function estimated by portable spirometry was well-correlated with that estimated by conventional 
spirometry. Although the values had minimal differences between them, we suggest that the spirometry results from the 
KNHANES are reliable.
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Introduction
The Korea National Health and Nutrition Examination Sur-
vey (KNHANES) is a well-designed survey of national data 
with a complex, multi-stage probability sample extraction1. It 
includes vast amount of data on demographics, underlying 
diseases, nutritional status, laboratory data, and even lung 
function. Recently, coronavirus, air pollutants, and climate 
changes have made respiratory medicine a focus point2-4. The 
KNHANES data have been widely used in researches on vari-
ous fields including respiratory medicine5-7. Several research-
ers have revealed that data on the prevalence and clinical 
characteristics of diseases are reliable under the premise that 
KNHANES represents all Koreans. Using KNHANES, Yoo et 
al.8 have reported that the prevalence of chronic obstructive 
pulmonary disease (COPD) estimated by spirometry was 
13.4%, and among them, only 2.4% had been clinically diag-
nosed with COPD. Additionally, Chung et al.9 have shown that 
the prevalence of a restrictive spirometric pattern was 12.2%. 
In the KNHANES, portable spirometry has been used to 
estimate lung function since July 2016. Portable spirometry is 
inexpensive, lightweight, and convenient to use, so that it has 
been used to establish the KNHANES data by conducting it in 
a moving bus. In the clinical setting, the non-movable conven-
tional spirometry is widely used, so the reliability of the new 
portable equipment requires verification with clinical and 
scientific evidence10,11. However, whether the portable spirom-
etry can be a substitute to conventional spirometry remains 
unclear. To accept study results from lung function data from 
the KNHANES, we need to confirm the reliability of portable 
spirometry. Thus, we aimed to verify whether data on lung 
function estimated by portable spirometry obtained through 
the KNHANES can be reliable.










Male sex 9 (45.0) 17 (81.0) 12 (70.6) 38 (65.5)
Age, yr 43.8±14.2 64.6±9.0 61.4±16.2 56.5±16.0
Recent symptom
   Cough 0 (0) 4 (19.0) 7 (41.2) 11 (19.0)
   Sputum 0 (0) 4 (19.0) 6 (35.3) 10 (17.2)
   Dyspnea 0 (0) 3 (14.3) 8 (47.1) 11 (19.0)
Inhaler medication
   Inhaled corticosteroids 0 (0) 12 (57.1) 2 (11.8) 14 (24.1)
   Long-acting β2-agonists 0 (0) 19 (90.5) 5 (29.4) 24 (41.4)
   Long-acting muscarinic antagonist 0 (0) 9 (42.9) 4 (23.5) 13 (22.4)
   Short-acting β2-agonists 0 (0) 2 (9.5) 0 (0) 2 (3.4)
Values are presented as number (%) or mean±standard deviation. 
Table 2. Results of intraclass correlation 
Variable
Intraclass correlation
Coefficient (95% CI) p-value
Total
   FVC 0.993 (0.988–0.996) <0.001
   FEV1 0.997 (0.995–0.998) <0.001
   FEV1/FVC ratio 0.995 (0.992–0.997) <0.001
   FEF25–75% 0.991 (0.984–0.994) <0.001
Normal pattern
   FVC 0.994 (0.986–0.998) <0.001
   FEV1 0.993 (0.983–0.997) <0.001
   FEV1/FVC ratio 0.954 (0.885–0.982) <0.001
   FEF25–75% 0.974 (0.934–0.990) <0.001
Obstructive pattern
   FVC 0.983 (0.958–0.993) <0.001
   FEV1 0.993 (0.982–0.997) <0.001
   FEV1/FVC ratio 0.991 (0.979–0.997) <0.001
   FEF25–75% 0.970 (0.926–0.988) <0.001
Restrictive pattern
   FVC 0.996 (0.990–0.999) <0.001
   FEV1 0.997 (0.991–0.999) <0.001
   FEV1/FVC ratio 0.970 (0.918–0.989) <0.001
   FEF25–75% 0.976 (0.933–0.991) <0.001
CI: confidence interval; FVC: forced vital capacity; FEV1: forced ex-
piratory volume in one second; FEF25–75%: forced expiratory flow 
at 25–75%.
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Materials and Methods
1. Participants
We prospectively enrolled 58 participants from four Ko-
rean institutions. We included participants who admitted to 
respiratory clinics of university hospital from August 12, 2020 
to November 11, 2020 and who are classified with following 
subgroups. Participants who cannot conduct spirometry were 
excluded. The participants were classified into normal pattern, 
obstructive pattern, and restrictive pattern groups according 
to their previous spirometry results. The normal pattern group 
was defined as participants without respiratory symptoms 
and underlying respiratory diseases. The obstructive pattern 
group was defined as those with underlying airway diseases 
including asthma or COPD and with an obstructive pattern 
in previous spirometry results (forced expiratory volume in 1 
second [FEV1]/forced vital capacity [FVC] ratio <0.7)
12. Lastly, 
the restrictive pattern group consisted of participants with un-
derlying restrictive diseases including interstitial lung diseases 
and with a restrictive pattern in previous spirometry results 
(predicted FVC <80%)13.
2. Study design
The patients were admitted to the hospital and underwent a 
lung function test using two distinct equipment: conventional 
spirometry and portable spirometry. They rested at least 1 
hour between the two tests. During the rest time, a short sur-
vey on demographics, symptoms, and medical history was 
conducted. The results estimated by the two equipment were 
compared. 
3. Spirometry
The four participating institutions utilize the same non-
portable conventional spirometry (Carefusion Vmax, Sen-
sorMedics, Milan, Italia) that measures lung function, which 
is widely used in Korea. These four institutions recruited 








































































































Figure 1. Scatter plot of FVC (A), FEV1 (B), the FEV1/FVC ratio (C), and FEF25–75% (D). FVC: forced vital capacity; FEV1: forced expiratory 
volume in 1 second; FEF25–75%: forced expiratory flow at 25–75%.
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two institutions, portable spirometry was conducted before 
conventional spirometry. In other two institutions, the order 
was reversed. Lung function tests were performed according 
to American Thoracic Society/European Respiratory Soci-
ety recommendations14. Briefly, the following protocol was 
conducted. The patients were oriented with the test, and they 
were asked to slightly elevate their heads. They were made to 
wear a nose clip and a mouthpiece. They inhaled completely 
and rapidly with a short pause (<1 second), and then exhaled 
maximally until no more air can be expelled while maintain-
ing an upright posture. The test was repeated as necessary (for 
a minimum of 3 maneuvers and a maximum of 8 maneuvers). 
The results met acceptability and reproducibility criteria. 
4. Portable spirometry
The portable spirometer (Vyntus Spiro, Vyaire Medical 
GmbH, Hoechberg, Germany) was provided by the depart-
ment of the KNHANES of the Korean Disease Control and 
Prevention Agency. Portable spirometry is constituted of light-
weight pneumotach handle and long cable which can connect 
to private computer or notebook. From a single screen, patient 
data can be entered, flow sensor calibrated, test performed, 
quality assessment checked, and patient data trended via Sen-
trySuite program. The detectable flow range is about zero to 
±16 L/sec. Resolution is about 1 mL/sec and accuracy is about 
±5% at 0.1 to 14 L/sec. Resistance is <0.05 kPa/L/sec at 10 L/sec. 
5. Ethics
This study was approved by the ethics committee, Institu-
tional Review Board (IRB) of four distinct institutions includ-
ing Gangnam Severance Hospital (number: 3-2020-0264). Pa-
tient informed consent was obtained from all the participants.
6. Statistical analysis
Results are expressed as mean±standard error. Sample 
size (minimum number, 42) was calculated based on previ-
ous study (alpha level, 0.5 and power, 0.95)10. The values of 
FVC, FEV1, FEV1/FVC, and forced expiratory flow at 25–75% 
(FEF25–75%) were followed normal distribution, and it was 
justified by Shapiro-Wilk test or Kolmogorov-Smirnov test. 
The intraclass correlation coefficient (ICC) and Pearson’s 
correlation were used to assess the reproducibility and cor-
relation between the results estimated by conventional and 
portable spirometry. ICC has been widely used to evaluate 
test-retest reliability. High ICC means high similarity between 
values form the same group. The significance of the different 
values estimated by two distinct types of spirometry was as-
sessed using the paired t-test. Bland-Altman analysis was also 
used to compare two measurements. All statistical analyses 
were performed using the IBM SPSS version 18.0 (SPSS Inc., 
Chicago, IL, USA). p-values <0.05 were considered statistically 
significant.
Results
1. Clinical characteristics of the patients
The normal pattern (n=20), obstructive pattern (n=21), and 
restrictive pattern (n=17) groups were evenly enrolled. Com-
pared to the normal pattern group (male, 45.0%), the patients 
in the obstructive (81.0%) and restrictive (70.6%) pattern 
groups were predominantly male. Moreover, the mean age 
of the obstructive (64.6 years) and restrictive (61.4 years) pat-
tern groups was higher than that of the normal pattern group 
(43.8 years). The normal pattern group had no respiratory 
symptoms and no history of inhaler use, in contrast to some 
patients in the other groups (Table 1).




   FVC 0.986 <0.001
   FEV1 0.994 <0.001
   FEV1/FVC ratio 0.990 <0.001
   FEF25–75% 0.981 <0.001
Normal pattern
   FVC 0.990 <0.001
   FEV1 0.988 <0.001
   FEV1/FVC ratio 0.915 <0.001
   FEF25–75% 0.949 <0.001
Obstructive pattern
   FVC 0.969 <0.001
   FEV1 0.989 <0.001
   FEV1/FVC ratio 0.984 <0.001
   FEF25–75% 0.956 <0.001
Restrictive pattern
   FVC 0.995 <0.001
   FEV1 0.994 <0.001
   FEV1/FVC ratio 0.943 <0.001
   FEF25–75% 0.953 <0.001
FVC: forced vital capacity; FEV1: forced expiratory volume in one 
second; FEF25–75%: forced expiratory flow at 25–75%. 
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2. Results of ICC
Altogether, the ICC of FVC (coefficient, 9.993; 95% confi-
dence interval [CI], 0.988–0.996), FEV1 (coefficient, 0.997; 
95% CI, 0.995–0.998), and FEV1/FVC ratio (coefficient, 0.995; 
95% CI, 0.992–0.997) was excellent (all p<0.001). Similarly, in 
the subgroup analysis, the ICC of FVC, FEV1, FEV1/FVC, and 
FEF25–75% was also excellent (coefficient, 9.954–9.997; all 
p<0.001) (Table 2). The scattered plot shows the excellent cor-
relation of all parameters (Figure 1).
3. Results of the Pearson’s correlation
Altogether, the Pearson’s correlation of FVC (coefficient, 
9.986), FEV1 (coefficient, 0.994), FEV1/FVC (coefficient, 
0.990), and FEF25–75% (coefficient, 0.981) were excellent (all 
p<0.001). In the subgroup analysis, Pearson’s correlation was 
also excellent (coefficient, 9.915–9.995; all p<0.001) (Table 3).
4. Comparison of values measured by conventional and 
portable spirometry
In the paired t-test, FVC estimated by portable spirometry 
(3.34 L) was slightly lower than that by conventional spirom-
etry (3.40 L, p=0.009). However, the FEV1 values estimated by 
portable spirometry (2.36 L) and conventional spirometry 
(2.37 L) were not significantly different (p=0.516). The FEV1/
FVC ratio estimated by portable spirometry (71.5%) was 
slightly higher than that by conventional spirometry (70.2%, 
p<0.001). In addition, FEF25–75% ratio estimated by portable 
spirometry (2.03 L) was slightly higher than that by conven-
tional spirometry (1.95, p=0.013) (Figure 2). Bland-Altman 
plot also showed good correlation of the values estimated be-
tween two instruments (Figure 3).
Discussion


















































































Figure 2. Comparison of FVC (A), FEV1 (B), the FEV1/FVC ratio (C), and FEF25–75% (D) conducted by portable spirometry and conventional 
spirometry. FVC: forced vital capacity; FEV1: forced expiratory volume in 1 second; FEF25–75%: forced expiratory flow at 25–75%.
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tion estimated by portable spirometry and conventional spi-
rometry. The representative indicators for reproducibility and 
reliability of the new method compared to the standardized 
method, ICC, and Pearson’s correlation, were significant in all 
three important parameters of lung function in total and in the 
subgroup analysis. Although some values were significantly 
different in the paired t-test, the differences were not clini-
cally significant. This study also indirectly supported and re-
enforced reliability of previous clinical study which used lung 
function data of KNHANES. 
Moreover, despite the correlation being generally excellent, 
the correlation of FEV1/FVC measured by ICC and Pearson’s 
correlation was not relatively ideal than that of FVC and FEV1. 
The FEV1/FVC is a critical indicator in diagnosing COPD. The 
presence of a post-bronchodilator FEV1/FVC<0.7 confirms the 
presence of persistent airflow limitation, which leads to the 
diagnosis of COPD. The range of FEV1/FVC is relatively small, 
so the FEV1/FVC is sensitive to various factors. The value may 
be changed because of biological variation15,16. Therefore, 
the recent national COPD guidelines suggest that the post-
bronchodilator FEV1/FVC ratio be confirmed by repeated 
spirometry on a separate occasion if the value is between 0.6 
and 0.817. We suggest that a modest correlation of the FEV1/
FVC estimated by portable and conventional spirometry can 
be explained by insignificant biological variation.
Here, the estimated value of FVC by portable spirometry 
was significantly lower than that by conventional spirometry. 
We speculated that this might be lead to relatively low sensi-
tivity to detect extremely low expiratory flow in final exhala-
tion by portable spirometry. The difference of the value was 
minimal at approximately 60 mL. Additionally, the FEV1/FVC 
measured by portable spirometry was significantly higher 
than that by conventional spirometry, although the differ-
ence was also minimal at approximately 1.3%. Although these 
minimal differences are not clinically significant, these differ-
ences could make the data on the prevalence of restrictive and 
obstructive diseases inaccurate. Hence, we should consider 
this significant difference when we interpret the clinical study 
results of lung function from the KNHANES data. 
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Figure 3. Bland-Altman plot of FVC (A), FEV1 (B), the FEV1/FVC ratio (C), and FEF25–75% (D). Black line represents 95% limits of agreement. 
FVC: forced vital capacity; FEV1: forced expiratory volume in 1 second; FEF25–75%: forced expiratory flow at 25–75%. 
HJ Park et al.
280 Tuberc Respir Dis 2021;84:274-281 www.e-trd.org
although its compactness can be a disadvantage because fre-
quent movement, crash, and adjustment can lead to several 
errors and breakdown of this vulnerable equipment. The con-
ventional spirometer is big, non-movable, accurate, and solid. 
Thus, it is more preferred than the portable one in the clinical 
setting to obtain accurate information. However, some institu-
tions cannot use conventional spirometry because of space, 
cost, and convenience. In the KNHANES, portable spirometry 
was used because this national study should be conducted in 
a moving bus that travels nationwide. However, studies have 
been insufficient to confirm the reliability of portable spirom-
etry. We, for the first time, aimed to reveal the reproducibility 
and reliability of portable spirometry used in KNHANES data.
Our study results suggest that lung function measured by 
portable spirometry is highly correlated with that by conven-
tional spirometry. If the physicians who use spirometry are 
highly trained specialists, then we can trust the results of the 
portable spirometry. In fact, the KNHANES employed special-
ists to perform the spirometry and have trained them regular-
ly. Additionally, the spirometry results have been periodically 
verified. Therefore, we suggest that the spirometry results of 
lung function from the KNHANES are reliable regardless that 
the data was estimated by portable spirometry.
We attempted to reduce the study bias through the fol-
lowing protocol. First, we evenly included participants with 
various types of respiratory diseases. Second, we recruited 
participants from four distinct institutions. Third, we used 
three analytic methods (ICC, Pearson’s coefficient, and paired 
t-test) to define reliability20. Nonetheless, this study has some 
limitations. First, this study had a relatively small population, 
so further studies with a larger sample size will more strongly 
support our hypothesis. Second, we did not analyze post-
bronchodilator lung function parameters. Third, we did not 
reveal the reliability of physicians who were engaged in the 
KNHANES. Thus, further extended studies will be helpful to 
re-confirm whether the lung function data of the KNHANES is 
reliable.
Lung function estimated by portable spirometry is well-
correlated with that estimated by conventional spirometry. 
However, the values of FVC, FEV1/FVC, and FEF25–75% esti-
mated using two types of spirometry have a small difference. 
We should consider this significant difference when we inter-
pret the clinical study results of lung function contained in the 
KNHANES data. Generally, we suggest that the spirometry 
results contained in the KNHANES is reliable.
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